Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Non-compliance in residues remains low
The EU monitors veterinary drug residues to help protect animals and consumers.

Chemical contaminants higher than other groups of substances

Non-compliance in veterinary drug residues remains low, according to figures published by the European Food Safety Authority.

Monitoring data from 2016 show that unauthorised substances and contaminants found in food-producing animals suggest high rates of compliance.

The figures come as regulations to strengthen the assessment of maximum residue limits are introduced by the European Medicines Agency.

The EU monitors veterinary drug residues to help protect animals and consumers. A total of 710,000 samples were reported in 2016, from 27 of the 28 EU Member States.

The 2016 data show that the percentage of non-compliance in targeted samples was 0.31 per cent, which is the range of 0.25 per cent to 0.37 per cent reported over the previous nine years.

Non-compliance for chemical contaminants like metals was higher than for other groups of substances. Non-compliance for resorcylic acid lactones, mycotoxins and anti-thyroid agents all decreased in 2016.

The highest and lowest frequencies of non-compliant samples for non-steroidal anti-inflammatory drugs and antibacterials, respectively, were reported in 2016 in comparison to previous years.

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.